Tilray, Inc. (TLRY) Reports Q3 Loss of $0.20, Revenues Rise 86%
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Tilray, Inc. Reports Third Quarter 2018 Earnings
November 13, 2018 4:05 PM ESTRevenue rises 85.8% to $10.0 (C$12.9) million in the third quarter and 78.9% to $27.6 (C$35.5) million year-to-date Tilray medical cannabis products available to patients in 12 countries on five continents Signed agreements to supply adult-use cannabis to consumers in eight Canadian provinces and territories Completed successful $475.0 (C$610.6) million Convertible Senior Notes offering in October
NANAIMO, British Columbia--(BUSINESS WIRE)-- Tilray,Inc. (Tilray or the Company) (NASDAQ: TLRY), a global leader in cannabis production and distribution, today... More
